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Abstract
Paromomycin is an aminoglycosidic antibiotic that targets the RNA of the bacterial small ribosomal subunit. It binds in the
A-site, which is one of the three tRNA binding sites, and affects translational fidelity by stabilizing two adenines (A1492 and
A1493) in the flipped-out state. Experiments have shown that various mutations in the A-site result in bacterial resistance to
aminoglycosides. In this study, we performed multiple molecular dynamics simulations of the mutated A-site RNA fragment
in explicit solvent to analyze changes in the physicochemical features of the A-site that were introduced by substitutions of
specific bases. The simulations were conducted for free RNA and in complex with paromomycin. We found that the specific
mutations affect the shape and dynamics of the binding cleft as well as significantly alter its electrostatic properties. The
most pronounced changes were observed in the U1406C:U1495A mutant, where important hydrogen bonds between the
RNA and paromomycin were disrupted. The present study aims to clarify the underlying physicochemical mechanisms of
bacterial resistance to aminoglycosides due to target mutations.
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Introduction
A well-known problem related to the use of antibacterial
compounds is the emergence of resistant bacterial strains [1].
Bacteria constantly improve their resistance techniques by utilizing
their abilities to mutate quickly. Their proliferation rate can be as
short as minutes [2], and bacteria can also easily incorporate DNA
from the environment. Therefore, there is a pressing need to
identify new antibiotics that specifically and efficiently target the
processes that are crucial for the life of the bacterial cell. One of
the pivotal molecules in the cell is the ribosome, which is a
macromolecular complex involved in peptide synthesis, and is
composed of ribosomal RNA (rRNA) and proteins. The ribosome
consists of two subunits: the small subunit (in prokaryotic
organisms called 30S) and the large subunit (50S). Several
antibiotics target various sites on the ribosomal subunits and
interfere with bacterial translation at different stages.
Three transfer RNA (tRNA) binding sites are located at the
interface between the 30S and 50S subunit (denoted as A, P, and
E). The A-site on the 16S rRNA of the 30S subunit contains the
binding site for most aminoglycosidic antibiotics [3,4]. The
nucleotide sequence of the A-site is highly conserved in all species
[5], making it difficult for bacteria to gain resistance against
aminoglycosides by simple random nucleotide substitutions, since
mutations in these conservative regions often lead to death of
bacterial cell [1,6]. However, studies have shown that bacteria
with only one mutation in the A-site, such as A1408G, which
resembles the eukaryotic sequence, were no longer susceptible to
aminoglycosides [7–9]. Furthermore, other experiments have
proven that several other single point mutations exist that can
successfully block the effect of these antibiotics [7,10,11].
However, aminoglycosides can bind to a variety of RNA targets
and their specificity toward the A-site is not high. Therefore,
finding out why a single base substitution in the A-site has such a
large effect on the susceptibility of bacteria to aminoglycosides is of
high relevance.
A variety of computational tools have emerged during the last
few decades with the specific aim of complementing experimental
structural approaches. In particular, molecular dynamics (MD)
simulations have demonstrated the potential for revealing the
dynamic and flexible properties of biomolecules at an atomic level
of detail. Although the application of MD simulations to RNA is a
relatively new field, much attention has been paid to adapt the
MD methodology to these specific biomolecules (see refs. [12–14]
for recent overviews of the improvements and achievements of the
use of MD for nucleic acids). Several computational studies have
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well as on the entire ribosome. MD simulations – classical [15],
replica-exchange [16] and targeted [17] – have shown that the
adenines A1492 and A1493 are very mobile in the absence of the
antibiotic. These bases are positioned opposite base 1408, and
their mobility has been shown to be important for the fidelity of
translation [17–22]. In the absence of the antibiotic, these
adenines are almost in equilibrium between the flipped-out and
flipped-in state, with a slight bias toward the flipped-in
conformation [23,24]. A1492 and A1493 are responsible for the
proper recognition of tRNA, and upon the approach of the
cognate tRNA, acquire an extra-helical position that accommo-
dates the tRNA in the A-site. Aminoglycoside binding causes
A1492 and A1493 to face to the outside of the 16S rRNA helix
toward the solvent [25–28], which promotes the incorporation of
near-cognate or non-cognate tRNAs. The MD studies mentioned
above have shown that in the absence of antibiotic, the intra-
helical state of A1492 and A1493 is energetically favored. Other
MD simulations of the model A-site RNA fragment in complex
with paromomycin [29], as well as with other aminoglycosides
[30], have focused on the RNA solvation patterns and antibiotic
binding free energies. Brownian dynamics simulation of the model
A-site [31] and the entire 30S subunit [32] have investigated
aminoglycoside association pathways and rates, but have not
focused on the intrinsic dynamics of the binding site. Moreover,
none of the theoretical studies to date have investigated the
properties of the mutant A-site structures.
In our previous study [33], we identified the differences in
physicochemical properties and internal dynamics of the model A-
site between the prokaryotic and the eukaryotic-resembling
structure when the adenine at position 1408 was substituted with
guanine. In that study, we showed that the A1408G mutation
affected the mobility of A1492 and A1493. We also observed that
in the intra-helical state, these adenines sometimes form hydrogen
bonds with the opposite base at position 1408. The base pair that
formed is more stable in the eukaryotic-like structure (when
guanine occupies position 1408) than in the prokaryotic structure
(with adenine in position 1408). Most likely, the increased stability
of this base pair has some hindrance to the binding of
aminoglycosides to the A-site of the eukaryotic ribosome. We also
observed that the A1408G substitution changes the electrostatic
potential inside the binding cleft. Aminoglycosides are ionized in
physiological pH [25,34], and therefore electrostatic interactions
are important for their proper binding.
Here, we have significantly extended our previous studies by
analyzing how other experimentally reported mutations affect the
features of the A-site RNA. We present the results of eight, 20 ns-
long MD simulations of the model A-site mutated in silico: three
single point mutants and one double mutant, both in the presence
and absence of an aminoglycoside, paromomycin. The mutated
sites were selected based on previous experimental studies
[7,10,11,35], where the authors compared the impact of different
mutations in the A-site of Mycobacterium smegmatis, Escherichia coli,
and other bacteria. The base substitutions that caused the most
pronounced changes in minimal inhibitory concentrations (MIC)
for selected bacterial species were chosen, especially in response to
treatment with paromomycin.
Results
To investigate the influence of specific mutations on the
physicochemical features of the 16S rRNA A-site, we performed
MD simulations on a total of four mutated model A-site RNA,
with and without the aminoglycoside representative, paromomy-
cin (see Figure 1 and Table 1 for an overview of the substitutions).
The crystal structure comprises two highly analogous A-sites,
which only differ slightly in their atomic b-factor values.
Therefore, all MD simulations and analyses were performed for
both sections of the molecule in order to obtain better statistics of
the observed properties and an increased sampling of the phase
space.
As a comparative reference we performed an additional MD
simulation of the wild-type bacterial sequence with bound
paromomycin (denoted NON_MUT_PAR). This reference simu-
lation preserved the majority of the bonds observed in the crystal
structure (Figure S1) and the bound paromomycin retained its
original conformation (root mean square fluctuations, RMSF, was
less than 0.9 A ˚; discussed below). The behavior of the wild type
bacterial A-site model without bound paromomycin was described
in our previous work [33], which we also refer to throughout this
study.
Structural fluctuations of the A-site
We analyzed the flexibility of the entire model A-site by
calculating the average root mean square deviation (RMSD) of
atomic positions and root mean square fluctuations (RMSF) of
Figure 1. The binding site of paromomycin. (a) The sequence of
the paromomycin binding site in the 16S ribosomal RNA (E. coli
numbering); the mutated bases in our MD study are colored light gray
and the arrows depict the applied mutations; the A1408G substitution
accounts for the most important difference between the prokaryotic (A)
and eukaryotic (G) sequence of the A-site and was previously analyzed
[33]. The complete simulated structure contains two symmetric binding
sites (A-sites) as in the crystal structure (PDB entry 1J7T). (b) A stick




In hospitals throughout the world, aminoglycosidic anti-
biotics are used to combat even the most severe bacterial
infections. However, the continuous emergence of resis-
tant bacteria has created an urgent need to improve these
antibiotics. Aminoglycosides bind to bacterial ribosomal
RNA. Experiments have shown that specific point muta-
tions in the RNA confer high resistance against aminogly-
cosides in bacteria. We performed molecular dynamics
simulations of the aminoglycosidic binding site model
after introducing various mutations. Here, we show that
even single nucleotide substitutions can significantly
change the physicochemical features of the binding site.
In addition, we hypothesize why certain mutations result
in bacterial resistance to aminoglycosides.
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from the initial structure, that was calculated for all heavy atoms,
did not exceed 2.9 A ˚ in every simulation (Figure S2). Previous
studies have shown that paromomycin stabilizes both the wild-type
[30,33] and the A1408G mutated [33] A-site RNA structure (for
base numbering see Figure 1a; throughout the paper the E. coli
numbering convention of the A-site is used). In this study, we
observed a similar stabilizing effect by the presence of paromo-
mycin on the single point mutant structures G1491U and
G1491A. A slightly less pronounced effect of paromomycin was
also observed in the U1495C simulation. The stabilizing effects are
reflected by the RMSF and RMSD values, which are shown in
Figure 2 and Figure S2, respectively. For example, in the structure
that contains the G1491U mutation without the drug, the bases
that were in proximity to the mutated site as well as on the
opposite strand of the RNA helix (i.e., A1408 and C1409) showed
larger fluctuations, particularly in one section of the RNA
fragment. In the presence of the antibiotic, all of the residues
became more conformationally restrained.
In contrast, the overall decrease in RMSF (Figure 2) or RMSD
(Figure S2) that occurred in the presence of the antibiotic was
substantially less in the simulation with the double mutation
(U1406C/U1495A vs. U1406C/U1495A_PAR). Unlike the other
simulations of RNA with paromomycin, the U1406C/
U1495A_PAR trajectory showed that the drug itself was more
dynamic and significantly changed its conformation (RMSF values
for the two paromomycin molecules in the structure: 2.99 and
1.59 A ˚). In addition, one paromomycin in the G1491A_PAR
simulation was characterized by a higher RMSF of 2.8 A ˚, which
indicated a change in conformation. This finding was confirmed by
visualizing the trajectory (discussed below). The elevated RMSF of
A1492, A1493, and A1408 were expected, since these three bases
form a bulge in the original crystal structure and their flexibility is
necessary for the fidelity of the translation process [17–22].
Mutations change the mobility of A1492 and A1493
In the MD simulations of the original crystal structure of the
model A-site without paromomycin [33] the adenines A1492 and
A1493 were flexible and acquired both extra and intra-helical
states. They moved from the flipped-out state to the flipped-in
conformation, through the minor groove of the RNA helix.
Three important conformations of A1492 and A1493 can be
distinguished [17,19–22,25–28]. Conformation (a), where both
adenines occupy the inside of the RNA helix (hA1492[½{45;50 ,
hA1493[½{45;40 ; see ‘‘Methods’’ for the definition of the h angle),
which is a conformation that prevents the binding of the
aminoglycoside and may also cause rejection of a non- or near-
cognate tRNA during the translation process. In conformation (b)
A1492 is flipped out (hA1492v{45 or hA1492w50 ) and A1493
stays inside the helix (hA1493[½{45;50 ); this conformation occurs
when the translation termination factor has to be recognized and
accepted. Finally, conformation (c), where both A1492 and A1493
are outside the RNA helix (hA1492v{45 or hA1492w50 , and
hA1493v{45 or hA1493w40 ), which occurs upon the acceptance
of a cognate tRNA and also enables aminoglycoside binding.
To quantify the variance of the conformations of A1492 and
A1493 acquired in MD simulations, we used the pseudo-dihedral
angle (h) between the conformationally stable base G1494 and
each of the adenines (Figure S3). From the distribution of the
measured values (Figure 3), the changes in adenine motions caused
by the mutations were observed. In addition, we calculated the
overall percentages of time that the adenines were inside the RNA
helix as another measurement of adenine flexibility (Table 2).
All of the conformations of A1492 and A1493 described above
were observed in the NON_MUT simulations (Figure 3, dots in
shades of gray). The G1491A and G1491U mutations restricted
the adenines to the flipped-in ensemble of states (a). The smallest
changes in the adenines’ movement were introduced by the
mutation U1495C, while the largest deviation from the original
NON_MUT simulation was seen in the U1406C/U1495A
simulation, where A1492 and A1493 were positioned outside of
the helix for the majority of the time (Table 2).
Experimental studies have shown that the G1491A and
G1491U mutations cause an increased read-through of the stop
codon [36]. Based on the data presented in Figure 3, we noticed
that the (b) area was almost not visited by the adenines in the
mutated structures – they move as a pair, while the termination
factor requires that only A1492 is in the flipped-out state [20,21].
This may cause an acceptance of a non-cognate tRNA in place of
a termination factor and lead to the read-through of a stop codon.
Conformations of A1492 and A1493 influence the shape
of the binding cleft
Visualization of the G1491A and G1491U trajectories showed
that the changes in base pairing and in the conformations of
A1492 and A1493 made the A-site more condensed and
compressed. We quantified these observations by calculating the
distances between four atoms of residues 1407, 1491, 1492, and
1493 that pointed to the inside of the binding cleft. To simplify the
presentation of these results, we have grouped the trajectory
conformations into five clusters (see Methods, Table S1 and Figure
S4). Figure 4 shows the distances between these four atoms in the
Table 1. Summary of MD simulations.
structure
with (paromomycin) without effect of introducing mutation
NON_MUT_PAR NON_MUT –
G1491A_PAR G1491A A is found in eukaryotic sequence [5,39] and confers resistance against paromomycin (up to 64-fold
increase in MIC values [10,74])
G1491U_PAR G1491U high resistance against paromomycin (512-fold increase in MIC [7])
U1495C_PAR U1495C resistance against paromomycin (128-fold increase in MIC in M. smegmatis [7] and 5-fold increase in T.
thermophilus [10])
U1406C/U1495A_PAR U1406C/U1495A high resistance against many aminoglycosides (w1000-fold increase in MIC for paromomycin [7,75])
Labeling of MD simulations used in the text and the effects of introducing the mutations. All simulations were performed with Naz and Cl
{ ions (for details see the
Methods section).
doi:10.1371/journal.pcbi.1002099.t001
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center of the cluster) of the most populated cluster.
In general, the cleft in the simulations with the mutated 1491
base was more compact than in the NON_MUT, even though
bases A1492 and A1493 moved to the flipped-in state in all three
simulations (NON_MUT, G1491A, and G1491U). We noticed
that the change of the cleft shape was caused by the shift of the
base pairing and the twisting of base 1491 (see visualization in
Figure S4). Although distances 1 and 4 were large in one section of
the RNA structure that was in the most populated cluster of the
G1491A simulation (Figure 4 and Figure S4b, left), the data
derived from the entire trajectory for both A-sites show that the
mutations of G1491 resulted in the same or smaller dimensions
of the binding site compared to the non-mutated structure
(Figure S5).
Mutation of G1491 to adenine (G1491A) and to uracil
(G1491U) allowed A1492 and A1493 to occupy the flipped-in
state for up to 87% of the simulation time (Table 2). Therefore, the
range of movement of A1492 and A1493 was reduced in these
mutants (Figure S6). Especially the movement of the adenines in
one of the A-sites of the G1491A mutant structure was more
restricted to the flipped-in state when compared to the NON_MUT
simulation (see also Figure 2, top). According to recent studies
[17,37], the decrease inmovability is associated with a change inthe
accuracy of translation. In this case, the predominantly constant
flipped-in position of A1492 and A1493 could result in a reduction
in the number of cognate tRNAs accepted. Therefore, protein
synthesis would be more prone to errors. On the other hand, it has
been postulated that antibiotic binding occurs in a stochastic gating
fashion [38], and thus a mutated A-site should be more resistant to
aminoglycosidic antibiotics, since the drug would have difficulty in
‘‘catching’’ the A-site in a conformation that had flipped-out
adenines. A recent experimental study [39] on the reverse mutation
in the yeast ribosome (i.e., with the A1491G mutation) showed an
analogous effect. The eukaryotic ribosome possessing a guanine in
the 1491 position was less resistant to aminoglycosides. Moreover,
there was a reduction in the frequency of translation error in the
absence of the drug.
In contrast, mutation of the U:U pseudo-pair (i.e., in the
simulations U1495C and U1406C/U1495A) caused A1492 and
Figure 2. RMSF [A ˚ngstrom] per residue. PAR denotes paromomycin; (*) the base is cytosine (C) in U1406C/U1495A and U1406C/U1495A_PAR;
(**) the base is adenine (A) in G1491A and G1491A_PAR, and uracil (U) in G1491U and G1491U_PAR; (***) this base is adenine (A) in U1406C/U1495A
and U1406C/U1495A_PAR, and cytosine (C) in U1495C and U1495C_PAR. The plot also shows the RMSF for the original, prokaryotic A-site structure
[33]. Two graphs for each simulation depict RMSF of two symmetric fragments of the structure.
doi:10.1371/journal.pcbi.1002099.g002
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the simulation time (Table 2 and Figure S6).
Substitutions of G1491 destabilize base pairing
We observed that mutations in the G1491 position resulted in a
change of the base pairing pattern near the substituted base. In the
starting conformation, base 1491 formed a hydrogen bond with
the opposite base C1409 (Figure 5a). These hydrogen bonds break
several times in the G1491A and G1491U simulations. As a result,
the C1409 base either pairs with A1492 (Figure 5b) or occupies the
flipped-out state (Figure 5c). This type of shift in base pairing is
commonly found in tertiary RNA structures [40], and it may
contribute to bacterial resistance by changing the shape and
volume of the binding site. A similar effect was also observed in
some of our previous simulations of the wild-type prokaryotic A-
site RNA fragment (for details see Ref. [33]); however, that shift
was caused by a loss of stability by U1406:U1495, which
prevented the flipped-in conformations of bases A1492 and
A1493. In contrast, these two adenines were positioned inside
the helix for the majority of the simulation time in the G1491A
and G1491U simulations (Table 2).
The 1491U:C1409 and 1491A:C1409 pairs, which contained
mutant G1491, were dynamic whenever they formed, and at times
the C1409 base flipped out of the helix where it was stacked with
either A1408 or A1410 (Figure 5c). Nevertheless, the G1491A
mutant structure was generally more conformationally stable than
the G1491U mutant. The base pair formed in the MD simulation
with adenine in the 1491 position lasted approximately two times
longer than with uracil in the same position (Table S2).
The U:U pair loses its stability upon double mutation
The U1406:U1495 pair (Figure 1a) is important for the
structural stability of the A-site and for proper distribution of
electrostatic potential inside the cleft [7,29]. Bound paromomycin
forms one direct and one indirect hydrogen bond with the O4
oxygens of both uracils. Therefore, we monitored the behavior of
Figure 3. Mobility of A1492 and A1493. The pseudo-dihedral angle distribution showing the relative positioning of A1492 and A1493 with
respect to A1494. Each plot presents the angle values sampled in both parts of the model A-site with the color variance indicating the sampling
density. The panels on the left depict the three most important conformations (see text for the detailed description). The definition of the h angle is
presented in Figure S3 and described in Methods.
doi:10.1371/journal.pcbi.1002099.g003





A1492 65.40 45.92 74.21 55.03 0.22 41.89 2.87 0.79 25.67 19.91
A1493 86.52 79.21 78.46 51.33 18.60 57.99 0.10 21.21 60.58 79.22
Percentage of simulation time when A1492 or A1493 was inside the helix (as
defined by the pseudo-dihedral angle pictured in Figure S3 and described in
the Methods section).
1data from our previous study, see Ref. [33].
doi:10.1371/journal.pcbi.1002099.t002
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influence the base pairing and contacts with the drug.
We found that the single mutants G1491U and G1491A did not
affect the stability of the U1406:U1495 pair and that the pair was
predominantly formed by two hydrogen bonds (Figure 6a and Table
S2). In contrast, the resulting 1406C:1495A pair from the U1406C/
U1495A simulation formed one hydrogen bond and was only
moderately stable (Figures 6b, 7b, and Table S2). Occasionally,
1406C was observed rotating to a position that was almost per-
pendicular to the base pair plane (Figure 7c). Nevertheless, the
1406C:1495A pair often adopted an experimentally observed pattern
(http://bps.rutgers.edu/atlas/bppattern/ac_5 [41]; Figure 7b).
The geometry and the partial charge distribution in this region
were completely altered in the double mutant. Figures 7a, 7b, and
7d show the difference in the atom types and their positions in the
original U1406:U1495 pair after introduction of the mutations. In
the original U:U pair, two oxygens, U1406(O4) and U1495(O4),
which were positioned inside the helix (Figure 7a), formed one
direct and one indirect hydrogen bond with the neamine core of
paromomycin (Rings I and II; Figure 1b). This moiety is present in
every aminoglycoside and serves as an anchor for positioning the
aminoglycosides in the A-site. By mutating the U:U pair to C:A,
the negative charge in the binding site that was provided by the
uracil oxygens is deleted, which prevents the formation of
important hydrogen bonds between the A-site and aminoglyco-
sides. In addition, steric interactions can hinder the binding of the
drug, since adenine is larger than uracil and occupies more space
inside the binding cleft. The geometry-related changes could have
been deduced from simple static structural modeling, however
MD simulations describe the complicated dynamics of the
hydrogen bonds that are formed between the nucleotides and
between RNA and paromomycin. Mutating both uracils broke the
U:U hydrogen bonding pattern and the adenines A1492 and
A1493 were not able to adopt the flipped-in conformation for a
longer period of time, making it easier for the aminoglycosides to
bind to thus changed site.
In the U1495C simulation, where only one of the uracils was
mutated to cytosine, the newly formed U:C pair was conforma-
tionally stable (Table S2), and at times even formed three
hydrogen bonds. The U:C pair adopted a well-known pattern,
called 4-carbonyl-amino [42] or cis W.C./W.C. [43] (Figure 7d),
although alternate periods of a transient, non-classical confor-
mation were also observed (Figure 7e). The mutated pair lacked
one oxygen on the inner side of the base pair plane, and the uracil
was often found situated deeper inside the helix than in the wild-
type U:U conformation. This positioning of uracil may also make
it more difficult for aminoglycosides to bind to a modified
conformation.
Double mutation of the U:U pair destabilizes bound
paromomycin
The visualization of trajectory revealed changes in the internal
dynamics of the A-site/paromomycin complex, which was a result
of mutations of the U1406:U1495 pair in the U1406C/
U1495A_PAR simulation. These changes were also observed in
the RMSF (Figure 2). Due to the mutations, paromomycin
changed its conformation (Figures 8a and 8b). Rings III and IV
form the ‘‘tail’’ of paromomycin (Figure 1b) and are generally
more mobile than the rest of the drug [32,44]. However, in the
U1406C/U1495A_PAR simulation, the centers of mass of rings
III and IV shifted as much as *3A ˚ (Figure S8). In one of the A-
sites, PAR(N2
000
) of ring IV formed a new hydrogen bond with the
G1489(O2P). In the second A-site, a new hydrogen bond was
formed between PAR(O3
000
) of ring IV and the 1406C(O2P). These
were not observed for any other simulation.
Inaddition, theposition ofthe coreoftheantibiotic(ringsI andII)
was altered (Figure S9). Ring I moved away from the bulge and left
room for A1492 and A1493. In one A-site, the PAR(N1) atom
formed a hydrogen bond with 1406C(O2), which led to the
disruption of the C:A base pair (Figure 9a). In the second A-site, the
C:A pair was formed with only one hydrogen bond, and the
PAR(O6) hydrogen bonded with 1406C(N4) (Figure 9b). In the non-
mutated A-site [4,29], PAR(N1) forms a tight hydrogen bond with
U1495(O4) (with the distance of 2.82 A ˚ and 2.72 A ˚ for the two A-
sites of the crystal structure [45], respectively). In addition, the bond
was maintained and had a mean distance of 2:79+0:12 ˚ A between
the mentioned atoms in the MD simulation of the original complex.
Another important hydrogen bond, which is mediated by a
water molecule, is formed between PAR(O6) and U1406(O4)
(distances in the X-ray structure are 2.62 A ˚ between PAR(O6) and
the OW oxygen of water molecules W8 or W54; and 2.59 and
2.41 A ˚ between W8(OW) and W54(OW), respectively, and
U1406(O4); numbering of atoms as in Figure 9d). The simulations
of the wild-type structure showed that towards the end of the
trajectory, a direct bond was formed between RNA and
paromomycin: first the distance between PAR(O6) and
U1406(O4) was 5:39+0:32 ˚ A, and after ca. 11 and 14 ns for
each symmetrical part of the structure, respectively, it decreased to
Figure 4. Distances inside the binding site in the most representative cluster. The inset presents the measured distances marked by dotted
black lines.
doi:10.1371/journal.pcbi.1002099.g004
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the formation of the corresponding bonds (Figure 9e) and
therefore could not support two very important contacts between
paromomycin and RNA. These mutations almost completely
prevented the proper binding of aminoglycosides in the mutated
A-site, which has been shown in MIC experiments performed by
Hobbie et al. [7,8].
Paromomycin was also dynamic in the G1491A_PAR simula-
tion. In one A-site, we observed a shift of the entire antibiotic, and
ring IV rotated around the bond that formed with ring III
(Figure 8c). However, this ring reorganization effect was less than
in the U1406C/U1495A_PAR simulation, and the hydrogen
bonds with the U1406:U1495 pair were preserved (Figure 9c). In
fact, paromomycin came closer to the RNA atoms in one of the A-
sites (Figures S7 and S8). The distance between U1406(O4) and
PAR(O6) diminished during the simulation, like in the wild-type
structure, which suggested that these atoms actually form a direct
hydrogen bond.
Figure 5. Trajectory snapshots. (a)–(c) The shift of base pairing observed in both simulations with the G1491 mutation. The pair formed with the
mutated base was unstable. (d) The flipped-out conformation of the A1408 base, observed for a limited time in the U1495C simulation, showing the
movability of bases in the bulge influenced by the U1495 mutation.
doi:10.1371/journal.pcbi.1002099.g005
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with paromomycin provided additional evidence that the
U1406C/U1495A substitution causes the antibiotic to be less
conformationally stable in the binding site and even allows for
A1492 and A1493 to move into the helix (Figure S7). Moreover,
we also observed differences in the range of movements of the
adenines between the NON_MUT_PAR and G1491A_PAR
simulations. The G1491A mutation caused the range to widen,
which indicated that the bound drug may be less effective [17,37].
Mutations of the uridines influence the electrostatic
potential of the A-site
We monitored the distribution of sodium ions and water molecules
inside the binding site, since the electrostatic interactions [25] and
indirect water-mediated bonding between paromomycin and RNA
[4,45] are important for the structural stability of the complex. The
analysis of the distribution of ions in the MD simulations without the
antibiotic can show how the mutations change the electrostatic
potential of the inner side of the RNA A-site helix.
In a simulation of the wild-type prokaryotic A-site [33] the area
of maximal sodium ion density (more than 0.053 ion per ˚ A
3
) was
situated in the position of the ring II of the superimposed
paromomycin. The locations of high ion density areas in the
G1491U and G1491A simulations were roughly similar
(Figures 10a and 10b), however in comparison with the ion
distribution around the wild-type structure, were shifted approx-
imately 2 A ˚ toward the phosphorous atom of A1493. This shift
indicates that only a minor change in the electrostatic potential
occurred inside the RNA bulge, which was most likely caused by
A1492 and A1493 predominantly occupying the flipped-in state.
The MD simulation performed for the RNA helix with a double
mutation of the U1406:U1495 pair showed larger deviations in the
distribution of ions compared to the wild-type structure. Figures 10c
and 10d show both of the structures in which these uracils were
substituted. We noticed that the U1495C mutation introduced
smallerchangesthantheU1406C/U1495A mutation.High sodium
ion density areas in the U1495C simulation were shifted
approximately 3 A ˚ towards the major groove (Figure 10c), while
in the structure with the doublemutation, they were located entirely
outside of the core of the binding site (Figure 10d). We noted that
the ion density closest to ring II of paromomycin was not present,
whichprovidesfurtherevidencethat the U1406:U1495pseudo-pair
plays an important role in the recognition of the A-site site by
aminoglycosidic antibiotics through electrostatic interactions.
Fewer water molecules gather inside the clefts with
single-point mutations
The analysis of water distribution inside the binding cleft
showed that in general, the G1491U, G1491A, and U1495C were
less hydrated than the wild-type structure. There were only a few
dense areas observed, which can be explained by the change in the
Figure 6. The number of hydrogen bonds formed between subsequent base pairs plotted versus simulation time. Data from
simulations: (a) G1491A and (b) U1406C/U1495A. Asterisks (*) indicate the mutated bases.
doi:10.1371/journal.pcbi.1002099.g006
Figure 7. Mutations of the U1406:U1495 pair. Exemplary
trajectory snapshots showing the interactions of the uracil pair before
(a) and after introducing mutations (b)–(e). Pairs of sub-figures: (b) and
(c), and (d) and (e) show different conformations of the base pair that
were observed in the simulations. Notice the change in the charge
carried by the mutated atoms: from negative charge (marked with red
circles) to positive (marked with blue squares).
doi:10.1371/journal.pcbi.1002099.g007
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observed in G1491A and G1491U) or simply by A1492 and
A1493 occupying the flipped-in state (which was observed in all
three simulations) (Figure S10a and Table S3).
Nevertheless, we observed an area of high water density
between U1406 and U1495 in both A-sites in the G1491A and
G1491U simulations (in the X-ray structure this water is
numbered W49; Table S3). This indicated that the
U1406:U1495 pair was correctly formed, since the hydrogen
bonds between these uracils are mediated by a water molecule
[45]. In our previous simulations of the original prokaryotic A-site
[33], these water density areas were also observed. In the U1495C
simulation, where only one uracil was mutated to cytosine, there
was a high water density area near U1406. This was most likely
due to the fact that U1406 was often shifted towards the inside of
the helix, which left space for water molecules to gather near
U1406(O2) (see Figure 7d for atom numbering).
Inside the structure with the double uracil mutation, we
observed more areas of high water density (Figure S10b); however,
none of these were between the mutated bases, and many were
located in positions where atoms of paromomycin were found after
superimposing the complex structure. These data suggest that
although the shape of the binding cleft is not altered in the
U1406C/U1495A simulation, there are still water molecules that
the antibiotic has to expel upon binding. Additionally, less
positions of crystal water molecules were reconstructed in the
U1406C/U1495A_PAR simulation compared to the NON_
MUT_PAR simulation (6 vs. 12; Table S4). These results further
confirm that paromomycin has weaker binding to the double
mutated A-site.
Discussion
In this study, we performed eight MD simulations of the model
RNA fragment that contained two symmetrically positioned A-
sites with various resistance-causing mutations introduced in silico.
The simulations were carried out for systems with and without the
aminoglycosidic antibiotic paromomycin. The comparative anal-
ysis of the trajectories showed differences in the physical and
chemical features of the A-site that were introduced by these
mutations.
U1406:U1495 mutations affect the electrostatic potential
inside the A-site
The U1406C/U1495A mutation (Figure 1a) was found to have
the biggest effect on the binding site of paromomycin, which is in
agreement with previous experiments that have shown changes in
the minimal inhibitory concentrations (MIC) of aminoglycosides
that target bacteria with different mutations in the A-site [8]. This
double mutation perturbs the electrostatic potential inside the
RNA helix, which in our simulations resulted in disabling the
formation of proper direct and indirect contacts between
paromomycin and the mutated bases.
Moreover, our simulations revealed that upon the change of
base 1495 from uracil (pyrimidine) to adenine (purine), the shape
of the base pair was disrupted. During the simulation, the adenine
is situated more inward than the uracil in the wild-type structure,
which can possibly prevent paromomycin binding by steric
hindrance. This apparent conformational change of the mutated
base pair did not seem to affect the other base pairs’ stability, and
throughout the simulation, the A-site model retained its overall
structure, which is in agreement with a previous study [46].
In all of the MD simulations of the complexes with the
antibiotic, with the exception of U1406C/U1495A_PAR, paro-
momycin was firmly bound to RNA, and the complex was less
conformationally dynamic than RNA alone. In contrast, the
U1406C/U1495A_PAR simulation showed that the drug changed
its conformation and slid out from the binding cleft, which
indicated that the hydrogen bonds formed with the mutated
structure were not stable. When comparing the simulations of
structures with mutations of the U:U pair, we noticed that the
U1495C substitution has a smaller overall effect than the U1495A
substitution, which is in agreement with the experimental studies
on affinities of paromomycin for ribosomal 30S subunits that
possess different mutations in the A-site [6].
Our studies, together with other works where more uracil
mutations have been tested [6,8] suggest that the negative
electrostatic potential created by base 1495 may be more
important for proper recognition of aminoglycosides than the
geometry of this base pair. The double mutation in this study
completely disrupted both features of the base pair, while the
U1495C preserved the shape and one of the negatively charged
Figure 8. Conformations of paromomycin in the A-site. Exemplary trajectory snapshots showing the change of the conformation of
paromomycin (compare (a) with (b) and (c)). Hydrogen atoms of paromomycin are not shown for clarity of the image.
doi:10.1371/journal.pcbi.1002099.g008
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PLoS Computational Biology | www.ploscompbiol.org 9 July 2011 | Volume 7 | Issue 7 | e1002099Figure 9. Hydrogen bonds formed by paromomycin with the RNA. Distances between the atoms of the U1406:U1495 pair and paromomycin
as a function of the simulation time along with the trajectory snapshots labeling the measured distances. Data taken from simulations (a)–(b)
G1491A_PAR and (c)–(f) U1406C/U1495A_PAR. Two plots depict values for the two A-sites of the crystal structure.
doi:10.1371/journal.pcbi.1002099.g009
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by Hobbie et al. maintained only the negative charge distribution
on the 1495 base. The U1406C/U1495G substitution had almost
no effect on the MIC value, which was elevated for the other two
mutations (U1406C/U1495A and U1495C).
The A-site bulge changes its shape due to 1491
mutations
Mutation of the G1491 base also induced a significant effect on
the A-site. Previous studies have shown that mutation of G1491 to
U and A conferred high levels of resistance to paromomycin
[8,11]. In the G1491U and G1491A simulations, we observed a
shift in the base pairing, including the mutated base. This shift
changed the internal dynamics of the binding site and enabled
A1492 and A1493 to occupy the flipped-in state for a longer
period of time, which could lead to steric clashes with
paromomycin and preclude its accommodation in the A-site.
Steric changes may influence the ability of aminoglycosides to
bind, and may have an even larger effect than changes in the
electrostatic potential [47]. Hobbie et al. has suggested that the
intra-helical side of adenine is less nucleophilic than that of
guanine, and therefore the G1491A substitution diminishes the
strength of the hydrogen bonds formed with the drug [7]. Our
results show that this mutation significantly changes the shape of
the cleft to a point where paromomycin may have difficulty fitting
into the binding site.
A previous study of the eukaryotic yeast A-site showed that the
A1491G substitution only caused a slight decrease in translation
error frequency [39]; however, it was shown to increase 10-fold in
the presence of the antibiotic. Therefore, the reverse mutation in
bacteria can reduce the effect of the bound aminoglycoside at the
expense of a slight increase in the translation error rate in the
absence of the drug. Our G1491A_PAR simulation showed that
A1492 and A1493 acquire conformations close to the flipped-in
state, which corresponds to the decreased effectiveness of the
antibiotic [17,37]. Moreover, in the simulation without the drug
(G1491A), these adenines stayed in the flipped-in state for a longer
period of time than in the wild-type structure, indicating a possible
increase in translation errors, which could occur by rejecting too
many tRNA molecules.
The MD simulations presented in this study also suggested a
cause for the increased probability of a stop codon read-through
due to the G1491A mutation that was previously reported [36]. In
comparison to the NON_MUT simulation, we noticed that A1492
and A1493 were almost never apart in the G1491A simulation.
However, in order to correctly recognize the termination factor,
A1493 must stay inside the A-site RNA helix and A1492 must be
flipped-out to form the necessary contacts [20,21]. Therefore,
changes in the movement of the adenines introduced by the
G1491A substitution reduces the probability that the termination
factor will be accepted.
It has been hypothesized that the mutation G1491U is more
evolutionary profitable than the G1491A substitution [48]. In this
Figure 10. Areas of sodium ion density in the free A-site. (a)–(c) *0.066 ions per ˚ A
3
, (d) *0.055 ions per ˚ A
3
; violet – MD simulations of the
original structure, and green – of the mutated structures. The superimposed position of paromomycin is shown for clarity. Only the U1406:U1495 and
A/G1408, A1492, A1493 bases are shown in atomic details. Hydrogen atoms were not shown for clarity of the image.
doi:10.1371/journal.pcbi.1002099.g010
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changes to the A-site model and that the flipped-in conformations
of the adenines A1492 and A1493 are much more stable in this
simulation than in the G1491U simulation and the wild-type
structure. This may explain the worse ‘‘fitness’’ of bacteria
possessing a G1491A substitution.
Moreover, we observed that the complexes of paromomycin
with either of the G1491-mutated structures are quite stable,
suggesting that in this case, the resistance comes from the smaller
percentage of binding-enabled conformations of the A-site in the
dynamic ensemble. It has been previously shown with combined
experimental and theoretical approaches [38] that in case of
aminoglycosides and the ribosome, binding is achieved through so-
called stochastic gating or conformational selection, and not an
induced fit mechanism. Therefore, the drug simply has a much
lower probability of finding a G1491A mutated A-site in a
favorable conformation.
Proposed modifications of paromomycin
We propose that an alteration of the substituent at the 2’’’
position of paromomycin ring IV (Figure 1b) may improve the
binding in the A-site, even with mutations of the U1406:U1495
bases. Specifically, substitution of the 2’’’{NHz
3 group with the
2’’’{CH2NHz
3 would allow the ring IV to interact with
phosphate groups of both G1405 and U1490 or G1491. In the
G1491A_PAR and G1491U_PAR simulations a bond was formed
between 6’’’{NHz
3 and O2P of the mutated base 1491, or even
with U1490(O2P). It existed either in place of or along with the
hydrogen bond between 2’’’{NHz
3 of paromomycin and
G1405(O2P). This was most likely due to the change in the shape
of the binding cleft in these simulations, since we did not observe
the former interaction in the other simulations, especially in the
NON_MUT simulation. However, with the proposed extension of
the 2’’’{NHz
3 paromomycin, ring IV may always be hydrogen
bonded to both sides of the major groove, which would anchor the
drug even more.
Similarly, the 6-OH group of ring II, which forms a water-
bridged hydrogen bond with U1406(O4) in the unmodified A-site
[29,45], could be substituted for CH2OH group. Thus, it may
form a direct hydrogen bond with the unmodified base U1406.
Moreover, if the amino group at 2’ position (ring I) was switched
with the OH substituent at 3’ position, the bonds formed with the
phosphate group of A1492 could be tighter, which would therefore
anchor the neamine part of the drug more (this interaction was
weak in the G1491A and the U1406C/U1495A simulations).
Important hydrogen bonds are also formed with the 3{NHz
3
group (ring II), but they are not stable in simulations of the
structures with mutated U1406:U1495 bases. We have noticed
that the distance between the nitrogen N3 of paromomycin and
phosphorous atom of either G1494 or A1493 is quite big after the
equilibration (an increase from *3.9 A ˚ up to 4.9 A ˚). Therefore,
an extension at this position (i.e., 3{CH2NHz
3 instead of a simple
amino group) could improve binding, which may also diminish the
effect of the double mutation U1406C/U1495A.
Methods
Starting structures and system preparation
We used a 44-nucleotide RNA model containing two
symmetrically positioned A-sites that were complexed with
paromomycin as the starting structure (Figure 1a depicts half of
the sequence of the model, Figure 1b shows the structure of
paromomycin; PDB code of the whole structure: 1J7T [45], 2.5 A ˚-
resolution). This rRNA region forms a helix with a bulge created
by the following three adenines: A1408, A1492, and A1493. The
chosen model proved to be a good representative of the original
binding site, which is a solvent-exposed region in the small
ribosomal subunit [33,49,50]. Since the model is deprived of the
influence of all the surrounding ribosomal RNA and proteins that
exist in the complete ribosome assembly, it could be questioned
whether the behavior of the nucleic bases, particularly of the two
adenines A1492 and A1493, can be reliably represented.
Therefore, we have compared the solvent accessible surface area
(SASA) of these adenines in different X-ray structures of the
ribosome with the values from the simulation of the model (Figure
S11; values were calculated with VMD software [51]). The range
of the values obtained from the simulation of the wild-type A-site
model were within the range calculated for the experimental static
structures. In this study we also investigate the geometry and
dynamics of the U1406:U1495 base pair. In the whole 70S
ribosome it is involved in some tertiary contacts (A1919 of 23S
rRNA and G1517 of 16S rRNA; see e.g., structures 3I8F and
3I8G [52]), which we are not able to mimic in our model.
Nevertheless, these bases form a stable pair in the wild-type
structure [33] and we did not observe bulged-out conformations of
either U1406 or U1495. These results provided additional
reassurance that the model in our simulations can reliably
reproduce the shape and internal dynamics of the A-site inside
the 30S ribosomal subunit.
Mutations were chosen based on previous experimental studies
[7,10,11] and were introduced using the Sybyl (Tripos) software.
We believe that a well-established protocol that includes
minimization followed by heating and equilibration of the whole
system (described below) yields a valid starting structure for the
further collection of the production phase data. We also performed
simulations of the RNA models with and without the drug, in
order to have a reference when seeking changes in the features of
the binding site that resulted from the presence of the bound
antibiotic. All of the types of MD simulations together with their
abbreviations used in the text are listed in Table 1.
The system was neutralized by adding sodium ions Naz around
the molecule with the use of LEaP from the Amber9 package [53].
In this step 44 and 34 ions were added to the structures without
and with paromomycin, respectively. The neutralized molecules
were then submerged into boxes of TIP3P [54] water molecules,
again with the use of the LEaP program. The dimensions of each
system were 92669669 ˚ A
3
. Finally, random water molecules were
substituted with 39 sodium (Naz, radius: 1.5 A ˚, mass: 22.99 a.u.)
and 39 chlorine (Cl
{, radius: 1.5 A ˚, mass: 35.45 a.u.) ions, in
order to obtain an ionic strength of approximately 150 mM.
Sodium ions were chosen because they were better represented in
the force field that was used than potassium ions, for example (see
ref. [29,55]). The Amber ff99 [56] force field was selected for the
RNA. A newer version of this force field is available, called
parmbsc0 [57], however we did not use it since we wanted to
compare the results with our previous simulations that utilized the
ff99. Moreover, recent studies showed that there is little difference
between these types of parametrization in relation to RNA
simulations [58,59]. Very recently, some improvements of RNA
force field parameters were proposed [60]. Banas ˇ et al. have shown
that even in the parmbsc0 force field, the x angle (i.e., the dihedral
angle of the linkage between the ribose and the nucleic base) may
adopt some non-standard values, leading to a so-called ‘‘ladder-
like’’ structure formation instead of a normal A-RNA helix. We
are aware that the parametrization of the RNA force field is far
from perfect; however, on short timescales (similar to our 20-ns
trajectories) and for simple tertiary structures (i.e., helical RNA) it
has been proven through many simulations that the experimental
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addition, the x angle in our simulations behaved well for all the
RNA sequences and we did not observe high-anti conformations
(see Figure S12). Moreover, our trajectories were not as long as
those tested in ref. [60], and therefore we believe that the
conformational changes reported here do not result from an
improper parametrization of RNA.
The parameters for paromomycin were created with the use of
antechamber program from Amber suite, using GAFF [61] force
field and AM1BCC charges. Since this is an automatic approach,
with no guarantee for yielding correct force field parameters, we
further tested the force field parameters. We performed two 10-ns
long MD simulations of paromomycin in water (with different
initial velocities) and compared some conformational features to
the existing NMR data [44] (see Figures S13 and S14). The work
of Asensio et al. analyzed NMR spectra of an aminoglycoside
neomycin, which differs from paromomycin in only one chemical
group (6’{NHz
3 in place of 6’{OH). This did not seem to
influence the flexibility of the drug, as our simulations showed a
very good correlation with the NMR-derived data. The complete
parameters are given in Supplementary Dataset S1.
Simulation protocol
The computational protocol was essentially the same as
previously described [33]. Briefly, the energy minimization was
carried out with the sander program of the Amber9 package.
Afterwards, the simulations were performed with NAMD [62]
under constant pressure (using the Langevin piston method [63])
and temperature (controlled by Langevin thermostat [64]) and
with periodic boundary conditions. Electrostatic interactions were
calculated using the Ewald Summation method (PME [65]). The
SHAKE [66] algorithm was used which allowed for a 2 fs
simulation time step. Thermalization from 30–310 K was
performed with constraints applied to all heavy atoms of the
RNA and, if applicable, paromomycin. The constraint coefficient
(k) was equal to 50 kcal=(mol: ˚ A
2
) for the first 85 ps of simulation
and then 25 kcal=(mol: ˚ A
2
) for another 35 ps. The constraints
were then gradually weakened during first 300 ps of the
equilibration stage. For the remaining 600 ps, the constraints
were applied only to heavy atoms of the terminal nucleotides
C1402 (Figure 1a; k~0,35kcal=(mol: ˚ A
2
),t oP atoms of C1498
(k~0,3kcal=(mol: ˚ A
2
), and to P atoms of G1403
(k~0,25kcal=(mol: ˚ A
2
). These values were adjusted so as to
obtain the fluctuations of the termini that corresponded to the
crystallographic temperature factors. The MD production stage
was performed under the same conditions as the second part of
equilibration and lasted 20 ns.
In general, the MD simulations performed under constant
temperature only sample configurations that are close to the
energetical minimum of the given biomolecule, and do not enable
crossing larger energetical barriers. Therefore, the trajectory can
be quite limited. In our study, each of the simulations was quite
short (20 ns), but the system includes two symmetrical binding
sites, which enlarge the conformational sampling space. In
addition, the analysis was mainly comparative between the
structures with different mutations. We did not specifically gather
statistics on nucleobase flipping.
Data analysis
We used standard measures to test the conformational stability
of molecules, including the root mean square deviation (RMSD) of
atomic positions from the initial structure and the root mean
square fluctuations (RMSF) of each residue. These were calculated
with the g_rmsf and g_rms programs from the GROMACS
package [67–69] for all non-hydrogen atoms.
3DNA software [70] was used to monitor hydrogen bonds
between the paired bases and the opening angle of the base pairs.
The detailed description of the method can be found in the
software manual, which is available at http://rutchem.rutgers.
edu/,xiangjun/3DNA.
For the description of A1492 and A1493 flipping, we define the
pseudo-dihedral angle h as the torsion angle between the lines
connecting the four atoms G1494(N1), G1494(P), A1492/3(P), and
A1492/3(N1) (Figure S3). Base 1494 was stably positioned in all
simulations and formed a pair with an opposite C1409. Therefore,
it served as a good reference for the flipped-in conformation. For
this study, we defined the flipped-in state of A1492 and A1493
when hA1492[½{45;50  and hA1493[½{45;40 , respectively. All
other values of h point to the base being outside of the RNA helix.
A similar measure has been employed in other studies to measure
the conformational variation of bases in RNA [16,71] and DNA
[72,73].
The clustering of conformations obtained from MD simulations
was performed by the ptraj program of AmberTools (version 1.3,
available at http://ambermd.org). Each trajectory was aligned
with the first frame in order to eliminate translations and rotations
of the structure. The terminal residues C1402 were not considered
during clustering because of the applied constraints. The average
linkage method was chosen with a maximum of five clusters, and
the clustering of the structures was performed according to the
RMS distance measure for all heavy atoms. Other maximal
numbers of clusters were tested, however the former settings gave
optimal results.
The calculation of sodium ions and water distribution inside the
binding cleft was performed with the use of MolDyAna software
(http://moldyana.icm.edu.pl/moldyana; see also Methods section
in [33]). VMD [51] and The PyMol Molecular Graphics System
(Schro ¨dinger, LLC., http://www.pymol.org) were used to visual-
ize trajectories and R environment (http://www.R-project.org) in
order to produce plots.
Supporting Information
Dataset S1 Topology file made with the use of LEaP
program of Amber suite, consisting all the parameters
of paromomycin.
(PDF)
Figure S1 Distances between the atoms of paromomy-
cin and RNA bases [A ˚] in the NON_MUT_PAR simulation
and in the X-ray structure (PDB code: 1J7T) [Vicens, Q.; Westhof,
E. Structure. 2001, 9, 647–58].
(PDF)
Figure S2 Average RMSD [A ˚ngstrom] with their standard
deviations; two graphs depict RMSD for two A-sites.
(PDF)
Figure S3 Pseudo-dihedral angles describing the varia-
tion in the conformations of A1492 and A1493. The angle
hA1493 is calculated as a torsion angle between the four atoms:
G1494(N1) – G1494(P) – A1493(P) – A1493(N1), as depicted by
black sticks (analogously for hA1492: G1494(N1) – G1494(P) –
A1492(P) – A1492(N1)). The exemplary snapshot is taken from the
NON_MUT simulation, with the values of the pseudo-dihedral
angles (in degrees) shown in brackets.
(PDF)
Figure S4 Conformations of bases forming the A-site in
the most populated clusters in different MD simula-
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black dotted lines; two snapshots per simulation correspond to two
A-sites in the crystal structure; for base numbering see the inset in
the Figure S5 and Figure 1a.
(PDF)
Figure S5 Distances between chosen atoms inside the
A-site as a function of the simulation time. Four sets of
graphs correspond to four distances (1, 2, 3, 4) depicted as black
dotted lines on a stick model of the A-site fragment; for base
numbering see Figure 1a. Grey and black lines are for two
simulated A-sites.
(PDF)
Figure S6 Representative structures of the clusters for
different MD simulations of the free A-site RNA, super-
posed with regard to phosphorous atoms. The structures from
each cluster are colored differently: 1 – green, 2 – blue, 3 – red, 4 –
yellow, 5 – cyan (see Table S1 for the cluster sizes). Adenines A1492,
A1493 and A1408 are shown in atomic detail.
(PDF)
Figure S7 Representative structures of the clusters for
different MD simulations of the A-site in the complex
with paromomycin, superposed with regard to phos-
phorous atoms. Structures from each cluster are colored
differently: 1 – green, 2 – blue, 3 – red, 4 – yellow, 5 – cyan
(see Table S1 for the cluster sizes). Paromomycin and A1492,
A1493 and A1408 are shown in atomic detail.
(PDF)
Figure S8 Distances between the centers of mass of
adenine phosphorous atoms, A1492(P) and A1493(P),
and paromomycin ring III (left) or ring IV (right). The
frequency distributions of the distances are shown next to each
graph. Black and grey lines correspond to the two A-sites of the
crystal structure.
(PDF)
Figure S9 Distances between the centers of mass of
adenine phosphorus atoms, A1492(P) and A1493(P), and
paromomycin ring I (left)o rr i n gI I( right). The frequency
distributions of the distances are shown next to each graph. Black and
grey lines correspond to the two A-sites of the crystal structure.
(PDF)
Figure S10 Areas of high water density (light blue, §0.23
water oxygens per ˚ A
3
) located in one part of the simulated
structure, superposed on the crystal structure of the complex with
paromomycin (PDB entry 1J7T). Only the U14060U1495 and A/
G1408, A1492, A1493 bases are shown in atomic details; spheres
show the positions of the crystal water oxygen atoms, the ones
which were identified in the simulation are marked in orange (see
also Table S3). Hydrogen atoms were not shown for clarity of the
image.
(PDF)
Figure S11 Solvent accessible surface area (SASA) [ ˚ A
2
]
of the two adenines A1492 and A1493, calculated for the
ribosome structures available in PDB in higher resolution (i.e.,
structures containing only phosphorous atoms were discarded).
The values are compared with an average and standard
deviation calculated for the NON_MUT simulation (for both
symmetrical parts of the model structure, without taking into
account the hydrogen atoms, since X-ray structures do not
contain these).
(PDF)
Figure S12 Average glycosidic torsion angle x, calculated
for all the residues in each simulation per each frame. The scale on
y axes spans the possible range of x (2180, +180); compare with
Figure 6 in [Bana ´s ˇ, P. et al., Journal of Chemical Theory and
Computation. 2010, 6, 3836–3849].
(PDF)
Figure S13 Dihedral angles of linkages between the
rings of paromomycin. The angles w and y are defined as in
[Asensio, J. L. et al.,C h e m i s t r y .2002, 8, 5228–40], an NMR
study of neomycin, which differs from paromomycin only with
one chemical group, having OH instead of NHz
3 .T h ev a l u e s
were collected during two independent 10-ns production
phases of MD of paromomycin in water (the two runs started
from the same minimized structure but with different initial
velocities).
(PDF)
Figure S14 Distances between chosen hydrogen atoms of
paromomycin, compared with values from an NMR study of
neomycin, which differs from paromomycin only with one chemical
group, having OH instead of NHz
3 . The experimental values are
taken from Table1 in[Asensio,J. L. et al., Chemistry.2002, 8, 5228–
40] and are as follows: 1 – H1Glc–H4Strp, 2 – H1Glc–H5Strp, 3 –
H1Glc–H3Strp, 4 – H1Glc–H5Rib,5 – H1Glc–H2Rib, 6 – H1Glc–
H3Rib, 7 – H1Rib–H5Strp, 8 – H1Rib–H4Strp, 9 – H1Rib–
H6Strp,10 – H2Rib–H6Strp, 11 – H1Rib–H4Rib, 12 – H1Ido–
H3Rib, 13 – H1Ido–H2Rib, 14 – H1Ido–H4Rib. The asterisks (*)
mark the distances that were described as larger than in the
experimental work.
(PDF)
Table S1 Distribution of the MD conformations into
clusters. Occupancy of each of the clusters derived from
different MD simulations; the cluster with the highest population
(occupancy) is underlined.
(PDF)
Table S2 Base pairing. Percentage of simulation time when
base pairs were formed (i.e., at least one hydrogen bond was
present). Two values are shown for each simulation corresponding
to two A-sites. 1 data from our previous study (Romanowska J.,
Setny P., Trylska J., J. Phys. Chem. B 2008); 2 this base is U in
G1491A, G1491U, NON_MUT and U1495C; and C in U1406C/
U1495A simulation; 3 this base is U in G1491A, G1491U and
NON_MUT; C in U1495C; and A in U1406C/U1495A
simulation; 4 this base is A in G1491A, and U in G1491U.
(PDF)
Table S3 Reproduction of the crystal water molecules
in simulations of the free A-site. Selected water molecules of
the 1J7T crystal structure and the corresponding water density
areas in MD simulations without the antibiotic. ‘‘z’’ denotes
water density areas higher than 0.22 water molecules per ˚ A
3
observed in the position of the corresponding crystallographic
water molecule; ‘‘{’’ denotes lack of high water density in this
position. Brackets denote analogous water molecules located in the
other symmetric part of the RNA fragment.
(PDF)
Table S4 Reproduction of the crystal water molecules
in simulations of the complexed A-site. Selected water
molecules of the 1J7T crystal structure and the corresponding
water density areas in the MD simulations with paromomycin.
‘‘z’’ denotes water density areas higher than 0.22 water molecules
per ˚ A
3
observed in the position of the corresponding crystallo-
graphic water molecule; ‘‘{’’ denotes lack of high water density in
Molecular Dynamics of the Mutated Ribosomal A-site
PLoS Computational Biology | www.ploscompbiol.org 14 July 2011 | Volume 7 | Issue 7 | e1002099this position. Brackets denote analogous water molecules located
in the symmetric part of the RNA fragment.
(PDF)
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